Drug-induced parkinsonism in the elderly: incidence, management and prevention (Q37976411)

26 August 2017

title

Drug-induced parkinsonism in the elderly: incidence, management and prevention (English)

1 reference

26 August 2017

1 reference

parkinsonian syndrome

1 reference

inferred from title

author name string

José Luis López-Sendón

series ordinal

1 reference

26 August 2017

María Angeles Mena

series ordinal

1 reference

26 August 2017

Justo García de Yébenes

series ordinal

1 reference

26 August 2017

publication date

1 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

1 reference

26 August 2017

page(s)

105-118

1 reference

A paradigm shift in brain research

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Drug-induced parkinson syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Neurodegeneration in normal brain aging and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Review: drug-induced parkinsonism in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Drug induced parkinsonism: a common cause of parkinsonism in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Underrecognition of tardive dyskinesia and drug-induced parkinsonism by psychiatric residents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Failure of recognition of drug-induced parkinsonism in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Milestones in atypical and secondary Parkinsonisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Drug-induced parkinsonism in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Prevalence of parkinsonism and Parkinson's disease in the Arosa Island (Spain): A community-based door-to-door survey

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Epidemiology of parkinsonism: Incidence, classification, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Risk for antipsychotic-induced extrapyramidal symptoms: influence of family history and genetic susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Smoking and Parkinson's disease: systematic review of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

The clinical spectrum of freezing of gait in atypical parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Neuroleptic-induced parkinsonism is associated with olfactory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Cognitive dysfunction in drug induced parkinsonism (DIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Perturbation in Mitochondrial Network Dynamics and in Complex I Dependent Cellular Respiration in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

The role of DAT-SPECT in movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Risk of extrapyramidal syndrome in schizophrenic patients treated with antipsychotics: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Extrapyramidal side-effects of antipsychotics in a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Domperidone: review of pharmacology and clinical applications in gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Cinnarizine-induced parkinsonism: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Calcium antagonist flunarizine hydrochloride affects striatal D2 dopamine receptors in the young adult and aged rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Verapamil-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Lithium-induced tremor treated with vitamin B6: a preliminary case series

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

A case of Parkinsonism due to lithium intoxication: treatment with Pramipexole.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Parkinsonism and amiodarone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Reversible parkinsonism and cognitive impairment with chronic valproate use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Risk of serious extrapyramidal symptoms in patients with Parkinson's disease receiving antidepressant drugs: a pharmacoepidemiologic study comparing serotonin reuptake inhibitors and other antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Can sertraline induce parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Severe worsening of parkinsonism in Lewy body dementia due to donepezil

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Glial dysfunction in parkin null mice: effects of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Analysis of the metabolism of haloperidol and its neurotoxic pyridinium metabolite in patients with drug-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Useless drugs are not placebos: lessons from flunarizine and cinnarizine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Side effects of antipsychotic drugs. Avoiding and minimizing their impact in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Long-term effects of tetrabenazine in hyperkinetic movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Electroconvulsive therapy in neuroleptic-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Improvement in drug-induced parkinsonism with electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11598540-000000000-00000

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease

21 January 2018

1 reference

12 December 2020

Reversible drug-induced parkinsonism. Clinicopathologic study of two cases

1 reference

12 December 2020

Drug-induced parkinsonism

1 reference

12 December 2020

Parkinsonism following neuroleptic withdrawal

1 reference

12 December 2020

Unrecognized parkinsonism in acute care medical patients receiving neurological consultations

1 reference

12 December 2020

Psychomotility and parkinsonism in treatment with neuroleptic drugs.

1 reference

12 December 2020

Nigral degeneration in acquired immune deficiency syndrome (AIDS)

1 reference

12 December 2020

The occurrence, distribution and physiological role of catecholamines in the nervous system

1 reference

12 December 2020

Psychosis in Parkinson's disease

1 reference

12 December 2020

Atypical antipsychotics: mechanism of action.

1 reference

12 December 2020

What is the risk of developing parkinsonism following neuroleptic use?

1 reference

12 December 2020

Movement disorders in 28 HIV-infected patients

1 reference

12 December 2020

[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]

1 reference

12 December 2020

HLA antigens in drug-induced parkinsonism

1 reference

12 December 2020

Drug-induced parkinsonism. Clinical aspects compared with Parkinson disease

1 reference

12 December 2020

MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies

1 reference

12 December 2020

Persistent drug-induced parkinsonism

1 reference

12 December 2020

Neuroleptic affinities for human brain receptors and their use in predicting adverse effects

1 reference

12 December 2020

Mortality, oxidative stress and tau accumulation during ageing in parkin null mice

1 reference

12 December 2020

Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambuí study)

1 reference

12 December 2020

NORADRENALINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD

1 reference

12 December 2020

Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms

1 reference

12 December 2020

Extrapyramidal and diencephalic syndrome in the course of largactil and serpasil treatments

1 reference

12 December 2020

Cigarette smoking: effects on cognitive functions and drug-induced parkinsonism in chronic schizophrenia

1 reference

12 December 2020

1 reference

12 December 2020

Extrapyramidal disorders after prolonged phenothiazine therapy

1 reference

12 December 2020

Hereditary Predisposition in Drug-Induced Parkinsonism

1 reference

12 December 2020

A survey of drug-induced extrapyramidal reactions

1 reference

12 December 2020

Drug-induced parkinsonism

1 reference

12 December 2020

Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility

1 reference

12 December 2020

Asymmetry in clinical features of drug-induced parkinsonism

1 reference

12 December 2020

An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia.

1 reference

12 December 2020

Parkinsonism associated with calcium channel blockers: a prospective follow-up study

1 reference

12 December 2020

Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone

1 reference

12 December 2020

[Drug-induced parkinsonism]

1 reference

12 December 2020

1 reference

12 December 2020

Prolonged drug-induced Parkinsonism

1 reference

12 December 2020

Effects of calcium antagonists on the dopamine system

1 reference

12 December 2020

Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs

1 reference

12 December 2020

Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates

1 reference

12 December 2020

10.2165/11598540-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1048313549

0 references

1 reference